The QARS1 gene helps cells make proteins by supporting one small step in the body’s protein-building process. If it does not work properly, cells may struggle to grow and function normally, with the brain often affected most. Pathogenic variants in both copies of the QARS1 gene are linked to a rare condition that can cause early seizures, developmental delay, low muscle tone, and sometimes a smaller than expected head size. Some people first learn about this gene during genetic testing for unexplained neurologic symptoms in a child.
What is a gene?
Genes are segments of DNA that hold information your cells use to make molecules or regulate processes in the body. Some genes carry the instructions for producing proteins, the working parts of cells. Others mainly help determine when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
QARS1Gene function
What if the gene works
The QARS1 gene helps cells make proteins by attaching glutamine to a helper molecule that places it into new proteins. This supports normal growth, brain development, and everyday cell function.
Risk
What if the gene does not work
When the QARS1 gene does not work well, it can cause early brain and development problems, often with developmental delay, seizures, and smaller head growth. Milder to more severe variants can influence when symptoms begin and how strongly they affect a child.
Treatment
What does that mean for your treatment
For the QARS1 gene, no gene-specific treatment or drug-selection approach is currently established. Care is based on the person’s symptoms and daily needs rather than on a QARS1-targeted medicine.
Conditions associated with QARS1
Gene function
What if the gene works
Your cells need a steady supply of correctly made proteins for everyday growth, repair, and maintenance. The QARS1 gene supports this by helping prepare one specific protein building block before it is used. This work happens in the main part of the cell, outside the mitochondria. Understanding how the QARS1 gene helps make proteins gives a clear picture of its day to day role.
The QARS1 gene helps attach glutamine, an amino acid, to its matching transfer RNA, a small carrier used in protein making. This prepares the correct building block for use at the right step.
Loaded transfer RNA can then bring glutamine to the cell’s protein making machinery. This lets cells place glutamine into a growing protein chain according to the genetic instructions.
By matching the right amino acid with the right carrier, the QARS1 gene supports accurate protein translation, the process of reading genes to make proteins. This helps routine cell work stay orderly and efficient.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, such as variations in appearance, metabolism, or how the body responds to environmental influences. Many do not have any noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Some variants in the QARS1 gene make its enzyme fold poorly, become unstable, or lose much of its activity, which can disrupt protein production in cells. Milder variants may leave some activity, while more severe variants can cause a larger loss of function. This range helps explain how QARS1 gene variants affect protein function and why, when both copies are affected, symptoms may start earlier and be more marked.
How variants are linked to conditions
Pathogenic variants in both copies of the QARS1 gene cause QARS1-related developmental and epileptic encephalopathy, a rare inherited condition. People with this diagnosis often have early-onset seizures and developmental delay, and some also develop progressive microcephaly and changes seen on brain imaging. This is a confirmed gene-disease link, so finding pathogenic QARS1 variants can establish the diagnosis.
A variant is not necessarily a diagnosis
Variants are a routine feature of human biology and are widely found across the general population. Most do not directly affect health and instead represent part of normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when several genes and environmental factors play a role. In other situations, though, one well-characterized variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For QARS1, risk is mainly shaped by inheritance rather than lifestyle. A child’s chance is higher when both parents carry a harmful QARS1 change, and this can be more likely in families with a known history of the condition or when parents are blood relatives.
Inheritance of QARS1 variants
QARS1-related conditions are inherited in an autosomal recessive pattern. This means a child must inherit two disease-causing variants in the QARS1 gene, one from each parent, to be affected. Parents who each carry one QARS1 variant are usually unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without either variant. In families asking how QARS1 variants are inherited, this pattern affects sons and daughters equally.
What does my QARS1 result mean for my family?
For families with a disease-causing QARS1 result, the pattern is usually recessive, which often means both parents are healthy carriers. Brothers and sisters may also be affected or may be carriers, even if they seem well. Other close relatives can sometimes carry the same change, so the result may matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
QARS1 genetic testing uses a blood or saliva sample to read the QARS1 gene and look for variants. Doctors may order a single-gene test or a broader test that checks many genes at once when they are trying to explain symptoms. Results may find a disease-causing variant, no relevant variant, or a variant whose health effect is still unclear.
When should I consider getting a genetic test?
Testing for the QARS1 gene may be considered when a child has unexplained early seizures, developmental delay, or a smaller-than-expected head size, especially if brain scans show changes. It can also help when there is a family history of a QARS1-related condition or a known QARS1 variant in the family.
A genetic result is only one part of your health story
A genetic result can be informative, but what it reveals varies with the condition and the kind of variant involved. Lifestyle, environment, age, and medical history also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or reacts to it at its target. This helps explain why the same medicine may work well for one person, have less effect in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may not work the same way for everyone. For many drugs, genes can influence both how strongly a medicine works and how the body handles it. Understanding this can support treatment choices that are better informed and more personalized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the QARS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor or pharmacist.
History
QARS1 entered the genetics literature as the name for the gene encoding glutaminyl tRNA synthetase, a protein that had already been studied for its basic role in cells before the gene itself drew clinical attention. In recent decades, awareness of this gene’s role has grown as sequencing made it easier to connect rare inherited gene variants with childhood neurologic conditions. Building on this early work, scientists reported that pathogenic variants in the QARS1 gene could underlie severe developmental and epilepsy related presentations in some families. These reports helped confirm QARS1 as part of a broader group of genes linked to rare neurodevelopmental conditions. Over time, descriptions became more precise as additional families were identified and the range of features was better defined.